The U.S. Food and Drug Administration has issued an alert to users of home blood glucose meters to a potential problem with test strip accuracy involving meters using GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) technology.

It's important to note that while the FDA notice involves a wide range of home glucose monitor brands, it only impacts a small subset of patients - those who are on certain drug therapies containing non-glucose sugars (such as maltose, galactose and xylose). These medications, which are frequently used in peritoneal dialysis patients and in surgery, can cause false highs on GDH-PQQ test strips.

If you have questions or concerns about the FDA warning, contact your doctor or diabetes educator. You can also read the official FDA notice for more information.

RELATED: Accu-Chek meter users can read this notice issued by manufacturer Roche.